238 related articles for article (PubMed ID: 25605724)
1. The inhibitor protein (IF1) of the F1F0-ATPase modulates human osteosarcoma cell bioenergetics.
Barbato S; Sgarbi G; Gorini G; Baracca A; Solaini G
J Biol Chem; 2015 Mar; 290(10):6338-48. PubMed ID: 25605724
[TBL] [Abstract][Full Text] [Related]
2. The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival.
García-Bermúdez J; Cuezva JM
Biochim Biophys Acta; 2016 Aug; 1857(8):1167-1182. PubMed ID: 26876430
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype.
Sánchez-Cenizo L; Formentini L; Aldea M; Ortega AD; García-Huerta P; Sánchez-Aragó M; Cuezva JM
J Biol Chem; 2010 Aug; 285(33):25308-13. PubMed ID: 20538613
[TBL] [Abstract][Full Text] [Related]
4. The role of the ATPase inhibitor factor 1 (IF
Sgarbi G; Barbato S; Costanzini A; Solaini G; Baracca A
Biochim Biophys Acta Bioenerg; 2018 Feb; 1859(2):99-109. PubMed ID: 29097244
[TBL] [Abstract][Full Text] [Related]
5. The F1Fo-ATPase inhibitor, IF1, is a critical regulator of energy metabolism in cancer cells.
Solaini G; Sgarbi G; Baracca A
Biochem Soc Trans; 2021 Apr; 49(2):815-827. PubMed ID: 33929490
[TBL] [Abstract][Full Text] [Related]
6. The Pro-Oncogenic Protein IF
Righetti R; Grillini S; Del Dotto V; Costanzini A; Liuzzi F; Zanna C; Sgarbi G; Solaini G; Baracca A
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834071
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of Arabidopsis thaliana mitochondrial F
Chen C; Meng Y; Shopan J; Whelan J; Hu Z; Yang J; Zhang M
J Plant Physiol; 2020 Nov; 254():153264. PubMed ID: 33032063
[TBL] [Abstract][Full Text] [Related]
8. The inhibitor protein (IF1) promotes dimerization of the mitochondrial F1F0-ATP synthase.
García JJ; Morales-Ríos E; Cortés-Hernandez P; Rodríguez-Zavala JS
Biochemistry; 2006 Oct; 45(42):12695-703. PubMed ID: 17042487
[TBL] [Abstract][Full Text] [Related]
9. PKA Phosphorylates the ATPase Inhibitory Factor 1 and Inactivates Its Capacity to Bind and Inhibit the Mitochondrial H(+)-ATP Synthase.
García-Bermúdez J; Sánchez-Aragó M; Soldevilla B; Del Arco A; Nuevo-Tapioles C; Cuezva JM
Cell Rep; 2015 Sep; 12(12):2143-55. PubMed ID: 26387949
[TBL] [Abstract][Full Text] [Related]
10. Glucose-modulated mitochondria adaptation in tumor cells: a focus on ATP synthase and inhibitor Factor 1.
Domenis R; Bisetto E; Rossi D; Comelli M; Mavelli I
Int J Mol Sci; 2012; 13(2):1933-1950. PubMed ID: 22408432
[TBL] [Abstract][Full Text] [Related]
11. The pro-oncogenic protein IF
Sgarbi G; Righetti R; Del Dotto V; Grillini S; Giorgio V; Baracca A; Solaini G
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166879. PubMed ID: 37689158
[TBL] [Abstract][Full Text] [Related]
12. Supercomplexes and subcomplexes of mitochondrial oxidative phosphorylation.
Wittig I; Carrozzo R; Santorelli FM; Schägger H
Biochim Biophys Acta; 2006; 1757(9-10):1066-72. PubMed ID: 16782043
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Inhibitory Factor Protein 1 Functions as an Endogenous Inhibitor for Coupling Factor 6.
Kawai M; Osanai T; Tanaka M; Magota K; Tomita H; Okumura K
J Cell Biochem; 2016 Jul; 117(7):1680-7. PubMed ID: 26659871
[TBL] [Abstract][Full Text] [Related]
14. The Multifaceted ATPase Inhibitory Factor 1 (IF1) in Energy Metabolism Reprogramming and Mitochondrial Dysfunction: A New Player in Age-Associated Disorders?
Gore E; Duparc T; Genoux A; Perret B; Najib S; Martinez LO
Antioxid Redox Signal; 2022 Aug; 37(4-6):370-393. PubMed ID: 34605675
[No Abstract] [Full Text] [Related]
15. Peptides Targeting the IF1-ATP Synthase Complex Modulate the Permeability Transition Pore in Cancer HeLa Cells.
Grandi M; Fabbian S; Solaini G; Baracca A; Bellanda M; Giorgio V
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731874
[TBL] [Abstract][Full Text] [Related]
16. Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors.
Issaq SH; Teicher BA; Monks A
Cell Cycle; 2014; 13(7):1152-61. PubMed ID: 24553119
[TBL] [Abstract][Full Text] [Related]
17. The mitochondrial inhibitor IF1 binds to the ATP synthase OSCP subunit and protects cancer cells from apoptosis.
Galber C; Fabbian S; Gatto C; Grandi M; Carissimi S; Acosta MJ; Sgarbi G; Tiso N; Argenton F; Solaini G; Baracca A; Bellanda M; Giorgio V
Cell Death Dis; 2023 Jan; 14(1):54. PubMed ID: 36690622
[TBL] [Abstract][Full Text] [Related]
18. IF1 promotes oligomeric assemblies of sluggish ATP synthase and outlines the heterogeneity of the mitochondrial membrane potential.
Romero-Carramiñana I; Esparza-Moltó PB; Domínguez-Zorita S; Nuevo-Tapioles C; Cuezva JM
Commun Biol; 2023 Aug; 6(1):836. PubMed ID: 37573449
[TBL] [Abstract][Full Text] [Related]
19. F
Tanton H; Voronina S; Evans A; Armstrong J; Sutton R; Criddle DN; Haynes L; Schmid MC; Campbell F; Costello E; Tepikin AV
Front Physiol; 2018; 9():833. PubMed ID: 30050450
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the role and mechanism of IF1 and STF1 proteins, twin inhibitory peptides which interact with the yeast mitochondrial ATP synthase.
Venard R; Brèthes D; Giraud MF; Vaillier J; Velours J; Haraux F
Biochemistry; 2003 Jun; 42(24):7626-36. PubMed ID: 12809520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
